Albemarle (ALB) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales were $1.08–$1.1 billion, down 21% year-over-year, mainly due to lower lithium pricing, but with record lithium production and 11% higher Specialties volumes.

• Adjusted EBITDA was $267–$283.6 million, with strong year-over-year gains in Specialties (+30%) and Ketjen (+76%).

• Cash from operations reached $545 million, with operating cash flow conversion at 204% (73% excluding a $350 million customer prepayment).

• Net income attributable to shareholders was $41 million, up from $2 million in Q1 2024, but net loss to common shareholders was $0.3 million after preferred dividends.

• The company is maintaining its 2025 outlook, supported by cost controls, global diversification, and minimal direct tariff impact.

Financial highlights

• Net sales declined 21% year-over-year to $1.08–$1.1 billion, mainly due to lithium price declines.

• Adjusted EBITDA margin improved by 400 basis points year-over-year to 24.8–26.3%.

• Adjusted diluted EPS was a loss of $0.18, excluding non-recurring items.

• SG&A costs reduced by over 20% year-over-year to $123.5 million.

• Free cash flow was slightly positive, even excluding a $350 million customer prepayment.

Outlook and guidance

• Full-year 2025 outlook maintained, with net sales expected between $4.9–$7.0 billion and adjusted EBITDA between $0.8–$2.7 billion, depending on lithium price scenarios.

• Energy Storage volumes projected to increase 0–10% in 2025; Specialties and Ketjen expect modest volume growth.

• Capital expenditures for 2025 forecasted at $700–$800 million, over 50% lower than 2024.

• Break-even free cash flow targeted for 2025, with robust liquidity and cost controls.

• Adjusted effective tax rate for 2025 expected between (40)% and 25%, depending on market prices and geographic mix.